Hereditary or Predisposition Cancer Genomics

​

Molecular testing looks for specific inherited changes (mutations) in a person’s genetic make-up. Genetic mutations may have multiple different effects on a patient’s health. Mutations that are harmful may increase a person’s chance, or risk, of developing a disease such as cancer. Inherited mutations are thought to play a role in 5-10% of all cancers. These particular conditions are considered hereditary and appropriate genetic testing may be used to determine an individual’s risk.

​

By analyzing a patient's DNA we are able to search for specific genetic variants that put one at an increased risk of Hereditary Cancer.

​

G7 Diagnostics uses the latest advances in Next Generation Sequencing (NGS) to analyze a patient’s sample. Thus, providing comprehensive reports of genetic variants and risk factors. The ordering physician, supported by our genetic counselors, is able to formulate a treatment protocol to address any negative findings. Awareness of one’s risk factors allows patients and their physicians to take a proactive, rather than reactive approach to managing identified risks.

​

Our Test Advantages

• Next Generation Sequencing with custom oligonucleotide-based target capture provides robust and clinically actionable data.

• Illumina sequencing of the coding regions.

• Analysis options include: full sequencing, common variant, Copy Number Variations referencing comprehensive clinical genetic databases.

• High depth coverage capable of detecting common and rare mutations.

• Turn Around Time of 2-3 weeks.

• Experience in genetic testing over 10 years.

• MS and PHD Scientists ensure accuracy of results.

• Each report is reviewed and signed off by Board Certified Clinical Molecular Geneticists.